Get the Stockscreener App
0.1118
7.37%
-0.0089
After Hours:
.11
-0.0018
-1.61%
Cellyan Biotechnology Co Ltd stock is traded at $0.1118, with a volume of 548.80K.
It is down -7.37% in the last 24 hours and down -71.91% over the past month.
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
See More
Previous Close:
$0.1207
Open:
$0.118
24h Volume:
548.80K
Relative Volume:
0.16
Market Cap:
$5.51M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.50%
1M Performance:
-71.91%
6M Performance:
-83.06%
1Y Performance:
-93.57%
1-Day Range:
$0.107
$0.1204
1-Week Range:
$0.107
$0.1224
52-Week Range:
$0.0961
$1.74
Cellyan Biotechnology Co Ltd Stock (HKPD) Company Profile
Name
Cellyan Biotechnology Co Ltd
Sector
Industry
Phone
-
Address
-
Compare HKPD vs MCK, COR, CAH, HSIC, AHG
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HKPD
Cellyan Biotechnology Co Ltd
|
0.1118 | 5.51M | 0 | 0 | 0 | 0.00 |
MCK
Mckesson Corp
|
866.64 | 101.04B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
306.92 | 58.57B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
220.22 | 50.99B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
86.37 | 9.63B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
0.75 | 642.53M | 14.85M | -136.07M | 7.25M | -0.4726 |
Cellyan Biotechnology Co Ltd Stock (HKPD) Latest News
Cellyan Biotechnology Shareholders Approve 1-for-20 Consolidation and Charter Overhaul - TipRanks
Cellyan Biotechnology Refreshes Board as Independent Director Resigns and Successor Named in September 2026 - TipRanks
Cellyan Biotechnology (NASDAQ: HKPD) Announces Extraordinary Meeting on September 21, 2026 for Share Consolidation Proposal - Kalkine Media
12 Industrials Stocks Moving In Thursday's Pre-Market Session - benzinga.com
Cellyan Biotechnology Calls September 21 EGM to Approve 1-for-20 Share Consolidation - TipRanks
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now - marketscreener.com
12 Industrials Stocks Moving In Wednesday's Pre-Market Session - benzinga.com
12 Industrials Stocks Moving In Tuesday's After-Market Session - Benzinga
12 Industrials Stocks Moving In Tuesday's Intraday Session - Benzinga
Cellyan Biotechnology (HKPD) Advances 3.61% as Shares Approach Key $0.44 ResistanceMA Cross Alert - vinanet.vn
Kam Leung Chan Net Worth (2026) - GuruFocus
Jingyan Wu Net Worth (2026) - GuruFocus
Shu Liu Net Worth (2026) - GuruFocus
Chenyu Andy Liang Net Worth (2026) - GuruFocus
Zifeng Wang Net Worth (2026) - GuruFocus
Mike Yao Zhou Net Worth (2026) - GuruFocus
Cellyan Biotechnology granted Nasdaq compliance extension; shares surge - MSN
Cellyan Biotechnology stock sinks 21% after hours: Here's what happened - MSN
12 Industrials Stocks Moving In Friday's Pre-Market Session - Benzinga
Cellyan Biotechnology Wins Second Nasdaq Grace Period to Fix Sub-$1 Share Price - TipRanks
Cellyan Biotechnology Stock Sinks 21% After Hours: Here's What Happened - Benzinga
Cellyan Biotechnology Gets 180-Day Nasdaq Grace Period on Bid-Price Rule - marketscreener.com
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance By Investing.com - Investing.com Nigeria
12 Industrials Stocks Moving In Thursday's After-Market Session - Benzinga
Thursday's after hours session: top gainers and losers - ChartMill
Cellyan Biotechnology Co., Ltd Receives Nasdaq Notice of Additional Compliance Grace Period - The Manila Times
Cellyan Biotechnology gets 180-day extension for Nasdaq compliance - Investing.com
Cellyan Biotechnology Receives Nasdaq Extension to Regain Minimum Bid Price Compliance - Quiver Quantitative
Nasdaq grants Cellyan Biotechnology (Nasdaq: HKPD) bid-price extension - Stock Titan
Cellyan Biotechnology Must Reach $1 Bid Price by Jan. 11 - Stock Titan
Cellyan Biotech (HKPD) Holds Steady Near Support After Minor DeclineMA Cross Alert - dars.gov.et
12 Industrials Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
[EFFECT] Cellyan Biotechnology Co., Ltd SEC Filing - Stock Titan
Cellyan Biotechnology (HKPD) Slides 3.78% to $0.40 as Biotech Volatility PersistsBox Spread - dars.gov.et
Cellyan Biotech (HKPD) Slides 7.6%, Testing Key Support at $0.39Channel Projection - newsline.com
Cellyan Biotechnology (NASDAQ: HKPD) files $200M shelf to sell shares, debt - Stock Titan
Cellyan Biotechnology (HKPD) director CHAN Kam Leung files initial Form 3 - Stock Titan
12 Industrials Stocks Moving In Wednesday's After-Market Session - Benzinga
[Form 3] Cellyan Biotechnology Co., Ltd Initial Statement of Beneficial Ownership - Stock Titan
Cellyan Biotechnology (HKPD) Chief Strategy Officer listed with no Form 3 transactions - Stock Titan
Cellyan Biotechnology (HKPD) CFO Liu Shu files initial ownership Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) director Zhou Mike Yao files initial Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) director Wu Jingyan submits initial SEC Form 3 - Stock Titan
Cellyan Biotechnology (HKPD) CEO and director files Form 3 with no share transactions - Stock Titan
Zhengye Biotechnology Holding Limited Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - Yahoo Finance
Cellyan Biotechnology (HKPD) Slumps 7.83%: Key Support at $0.50 Under PressureFibonacci Fan - The Legal Advocate
Cellyan Biotechnology (HKPD) Holds Steady Near Support After Marginal GainsAdvance Decline Volume - The Legal Advocate
HKPDCellyan Biotechnology Co Ltd Stock Price and Quote - Finviz
Cellyan Biotechnology (HKPD) Drops 3.6% as Shares Approach Critical $0.50 SupportButterfly Setup - The Legal Advocate
Cellyan Biotechnology Faces Resistance at $0.57 After Recent DeclineSeasonality Effect - po-news-eg.net
Cellyan Biotechnology Co Ltd Stock (HKPD) Financials Data
There is no financial data for Cellyan Biotechnology Co Ltd (HKPD). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.28%
7.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):